Literature DB >> 17184994

Two alphaherpesvirus latency-associated gene products influence calcitonin gene-related peptide levels in rat trigeminal neurons.

Mohamed A Hamza1, Dennis M Higgins, William T Ruyechan.   

Abstract

Herpes simplex virus type-1 (HSV-1) initially infects mucoepithelial tissues of the eye and the orofacial region. Subsequently, the virus is retrogradely transported through the axons of the trigeminal sensory neurons. HSV-1 establishes a life-long latent infection in these neurons, during which the transcription of the viral genome is silent, except for the sequences encoding the latency-associated transcript (LAT). To determine if HSV-1 latency might affect calcitonin gene-related peptide (CGRP) expression in trigeminal sensory neurons, we transfected primary neuronal cultures of trigeminal ganglia from rat embryos with plasmids expressing LAT. In the presence of Bone Morphogenetic Protein-7 (BMP7), CGRP was expressed in 49% of sensory neurons. However, this percentage was reduced to 19% in neurons transfected with LAT expressing plasmids. We also found that transfection of the IE63 gene of varicella-zoster virus (VZV) reduced the percentage of trigeminal neurons containing CGRP. However, the observed effect of IE63 in contrast to that of LAT was completely reversed by treatment of cultures with MgCl2, which indicates that the effect of IE63 was due to increased release of CGRP from trigeminal neurons. We provide here the first evidence that HSV-1 LAT decreases the level of CGRP in trigeminal neurons. These effects may be important for reducing the neuroinflammatory response, thus protecting host neuronal cells during HSV-1 latency in trigeminal neurons. In contrast, increased release of CGRP in the presence of IE63 protein may contribute to the neuralgias associated with VZV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184994      PMCID: PMC1853241          DOI: 10.1016/j.nbd.2006.10.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  33 in total

1.  Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript.

Authors:  G C Perng; C Jones; J Ciacci-Zanella; M Stone; G Henderson; A Yukht; S M Slanina; F M Hofman; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

Review 2.  Herpes virus latency in sensory ganglia--a comparison with endogenous neuronal gene expression.

Authors:  J P Quinn; R G Dalziel; A A Nash
Journal:  Prog Neurobiol       Date:  2000-02       Impact factor: 11.685

Review 3.  Cellular mechanisms of neurogenic inflammation.

Authors:  Jennelle Durnett Richardson; Michael R Vasko
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

4.  An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system.

Authors:  V Limmroth; Z Katsarava; B Liedert; H Guehring; K Schmitz; H C Diener; M C Michel
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

5.  Skin cell induction of calcitonin gene-related peptide in embryonic sensory neurons in vitro involves activin.

Authors:  A K Hall; K J Dinsio; J Cappuzzello
Journal:  Dev Biol       Date:  2001-01-15       Impact factor: 3.582

6.  Herpesvirus hominis: isolation from human trigeminal ganglion.

Authors:  F O Bastian; A S Rabson; C L Yee; T S Tralka
Journal:  Science       Date:  1972-10-20       Impact factor: 47.728

Review 7.  Varicella zoster virus latency, neurological disease and experimental models: an update.

Authors:  Randall J Cohrs; Donald H Gilden; Ravi Mahalingam
Journal:  Front Biosci       Date:  2004-01-01

8.  Allodynia in rats infected with varicella zoster virus--a small animal model for post-herpetic neuralgia.

Authors:  Robert G Dalziel; Sharon Bingham; David Sutton; Dawn Grant; Jean M Champion; Shelley A Dennis; John P Quinn; Chas Bountra; Margo A Mark
Journal:  Brain Res Brain Res Rev       Date:  2004-10

9.  Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons.

Authors:  Paul L Durham; Penny X Dong; Kevin T Belasco; Jeffrey Kasperski; William W Gierasch; Lars Edvinsson; Donald D Heistad; Frank M Faraci; Andrew F Russo
Journal:  Brain Res       Date:  2004-01-30       Impact factor: 3.252

Review 10.  Herpes simplex virus type 1 and bovine herpesvirus 1 latency.

Authors:  Clinton Jones
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

View more
  4 in total

Review 1.  Transforming growth factor-β in normal nociceptive processing and pathological pain models.

Authors:  Aquilino Lantero; Mónica Tramullas; Alvaro Díaz; María A Hurlé
Journal:  Mol Neurobiol       Date:  2011-11-29       Impact factor: 5.590

2.  CGRP inhibits human Langerhans cells infection with HSV by differentially modulating specific HSV-1 and HSV-2 entry mechanisms.

Authors:  Emmanuel Cohen; Jammy Mariotton; Flore Rozenberg; Anette Sams; Toin H van Kuppevelt; Nicolas Barry Delongchamps; Marc Zerbib; Morgane Bomsel; Yonatan Ganor
Journal:  Mucosal Immunol       Date:  2022-05-13       Impact factor: 8.701

3.  Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin.

Authors:  J-M G Guedon; M Zhang; J C Glorioso; W F Goins; P R Kinchington
Journal:  Gene Ther       Date:  2014-05-15       Impact factor: 5.250

Review 4.  Modeling Varicella Zoster Virus Persistence and Reactivation - Closer to Resolving a Perplexing Persistent State.

Authors:  Lillian Laemmle; Ronald S Goldstein; Paul R Kinchington
Journal:  Front Microbiol       Date:  2019-07-24       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.